EFTA01582202

Statement of Account *" ALL AMOUNTS IN US DOLLAR *** TYPE DATE TRANSACTION QUANTITY 01 03/06 SOLD -1,000,000 01 03/07 WIRED 01 03/08 JOURNAL 01 03/08 JOURNAL 01 03/08 JOURNAL 01 03/08 MRKD/MARKET 03 03/08 MRKD/MARKET 03 03/08 JOURNAL -700 03 03/08 JOURNAL so o 03 03/08 JOURNAL 200 03 03/08 JOURNAL 200 03 03/08 SOLD -500 03 03/08 BOUGHT 700 03 03/08 SOLD -200 01 03/09 JOURNAL CREDIT SUISSE INV REP ACCOUNT TAXPAYER ID. STATEMENT PERIOD PAGE UNDISCLOSED 03/01/06 TO 03/31/06 8 OF 14 TRADING ACTIVITY FOR THE MONTH DESCRIPTION AMYLIN PHARMACEUTICALS INC SR 02.5000 04/15/2011 DONE AT DEUTSCHE BNK/ALEX BROWN FUNDS RECEIVED BY WIRE HIGUBRIDGE CAPITAL MANA S/D FINANCING RETURN FROM TO S/D FINANCING FROM TO FROM USD/GBP MARK TO MARKET MARK TO MARKET RPM INCORPORATED OFFSHORE ARRANGING FLIP TO FROMapp i AMERICAN FINL C OFFSHORE ARRANGING FLIP TO FROM CS% CORPORATION OFFSHORE ARRANGING FLIP TO FROM CS% CORPORATION OFFSHORE ARRANGING FLIP TO FROM AMERICAN FINL GROUP INC DONE AT EDGETRADE.COM INC. RPM INCORPORATED DONE AT EDGETRADE.COM INC. CS% CORPORATION DONE AT EDGETRADE.COM INC. S/D FINANCING RETII. FROM TO CREDIT SUISSE SECURITIES (USA) LLC ELEVEN MADISON AVENUE NEW YORK, NY 10010-3629 PRICE 139.37900 DEBIT CREDIT 1,403,581.67 12,694.00 28,001.16 28,001.16 29,931.74 11,324.03 11,324.03 12,643.47 20,710.46 11,324.03 11,324.38 41.42770 20,710.46 18.05660 12,643.47 56.62740 11,324.38 23,653.91 TEL: 212-325-2000 FAX: 212-538-5540 Confidential Treatment Requested by JPMorgan Chase JPM-SDNY-00061716 EFTA01582202